| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1023979696 |
| P356 | DOI | 10.1007/S00125-012-2789-5 |
| P932 | PMC publication ID | 3565067 |
| P698 | PubMed publication ID | 23232640 |
| P5875 | ResearchGate publication ID | 233901138 |
| P2093 | author name string | Z Xu | |
| H A Toque | |||
| M Rojas | |||
| R B Caldwell | |||
| R W Caldwell | |||
| S C Elms | |||
| P2860 | cites work | Arginine metabolism: nitric oxide and beyond | Q24531285 |
| Mouse model for human arginase deficiency | Q24537542 | ||
| Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies | Q24656109 | ||
| Arginase-boronic acid complex highlights a physiological role in erectile function | Q27620108 | ||
| The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine | Q29547539 | ||
| Improved leukocyte tracking in mouse retinal and choroidal circulation. | Q32109990 | ||
| Impaired retinal circulation in patients with type 2 diabetes mellitus: retinal laser Doppler velocimetry study | Q33632944 | ||
| Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator | Q34209959 | ||
| Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system | Q34477324 | ||
| Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease | Q34479731 | ||
| Modulating role of estradiol on arginase II expression in hyperlipidemic rabbits as an atheroprotective mechanism | Q34772312 | ||
| Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway | Q34979275 | ||
| Arginase II deletion increases corpora cavernosa relaxation in diabetic mice | Q35050926 | ||
| Endothelial arginase II and atherosclerosis | Q35161493 | ||
| Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway | Q35708220 | ||
| Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines | Q35749970 | ||
| Diabetes-induced vascular dysfunction involves arginase I | Q35906453 | ||
| Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages | Q36244224 | ||
| Ozagrel attenuates early streptozotocin-induced constriction of arterioles in the mouse retina | Q36646301 | ||
| Retinal blood flow in diabetes | Q36761967 | ||
| Lack of inducible nitric oxide synthases attenuates leukocyte-endothelial cell interactions in retinal microcirculation | Q36940984 | ||
| Arginase and vascular aging | Q36977086 | ||
| Arginase activity mediates retinal inflammation in endotoxin-induced uveitis. | Q37278531 | ||
| Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? | Q37483486 | ||
| Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine | Q39269807 | ||
| Diabetes-induced coronary vascular dysfunction involves increased arginase activity | Q41817278 | ||
| Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry | Q42285845 | ||
| Attenuation of streptozotocin-induced microvascular changes in the mouse retina with the endothelin receptor A antagonist atrasentan | Q42400411 | ||
| Ischemia‐reperfusion selectively impairs nitric oxide‐ mediated dilation in coronary arterioles: counteracting role of arginase | Q42451488 | ||
| Vasodilator effects of flunarizine on retinal blood vessels in anesthetized rats | Q43232670 | ||
| Classical and slow-binding inhibitors of human type II arginase | Q43691595 | ||
| Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase | Q43952389 | ||
| Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels | Q44601105 | ||
| Angiotensin AT 1 receptor antagonism normalizes retinal blood flow and acetylcholine-induced vasodiliation in normotensive diabetic rats | Q44656168 | ||
| Diabetes induces pulmonary artery endothelial dysfunction by NADPH oxidase induction. | Q45086457 | ||
| Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles | Q45113050 | ||
| Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension | Q45182794 | ||
| Hyperglycemia accelerates impairment of vasodilator responses to acetylcholine of retinal blood vessels in rats. | Q45981918 | ||
| C-reactive protein inhibits endothelium-dependent nitric oxide-mediated dilation of retinal arterioles via enhanced superoxide production | Q46626730 | ||
| Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells | Q46670067 | ||
| Biochemical and functional profile of a newly developed potent and isozyme-selective arginase inhibitor | Q48131599 | ||
| Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters | Q73316899 | ||
| Mitochondrial arginase II modulates nitric-oxide synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells | Q79792606 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 654-662 | |
| P577 | publication date | 2012-12-12 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes | |
| P478 | volume | 56 |
| Q37242111 | Acute and Chronic Hyperglycemia Elicit JIP1/JNK-Mediated Endothelial Vasodilator Dysfunction of Retinal Arterioles |
| Q35555144 | Adrenergic and serotonin receptors affect retinal superoxide generation in diabetic mice: relationship to capillary degeneration and permeability |
| Q35217395 | Angiotensin II-induced arterial thickening, fibrosis and stiffening involves elevated arginase function |
| Q34465434 | Arginase 2 deficiency prevents oxidative stress and limits hyperoxia-induced retinal vascular degeneration |
| Q37620647 | Arginase 2 deficiency reduces hyperoxia-mediated retinal neurodegeneration through the regulation of polyamine metabolism |
| Q37603245 | Arginase 2 promotes neurovascular degeneration during ischemia/reperfusion injury |
| Q41285088 | Arginase as a mediator of diabetic retinopathy |
| Q38082329 | Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? |
| Q34800913 | Arginase in retinopathy |
| Q41572196 | Arginase inhibition prevents bleomycin-induced pulmonary hypertension, vascular remodeling, and collagen deposition in neonatal rat lungs |
| Q36854784 | Arginase promotes skeletal muscle arteriolar endothelial dysfunction in diabetic rats |
| Q50143099 | Arginase: A Multifaceted Enzyme Important in Health and Disease. |
| Q38452432 | Arginase: an old enzyme with new tricks |
| Q42113401 | Assessment of serum arginase I as a type 2 diabetes mellitus diagnosis biomarker in patients |
| Q61797178 | Augmented contractility of murine femoral arteries in a streptozotocin diabetes model is related to increased phosphorylation of MYPT1 |
| Q42123271 | Blockade of vascular endothelial growth factor receptor 1 prevents inflammation and vascular leakage in diabetic retinopathy. |
| Q39430910 | Coronary microvascular disease as an early culprit in the pathophysiology of diabetes and metabolic syndrome |
| Q41384119 | Effects of the Hydroalcoholic Extract of Zingiber officinale on Arginase I Activity and Expression in the Retina of Streptozotocin-Induced Diabetic Rats |
| Q38928508 | Growth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus |
| Q91741207 | HuangqiGuizhiWuwu Decoction Prevents Vascular Dysfunction in Diabetes via Inhibition of Endothelial Arginase 1 |
| Q48835562 | Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes |
| Q46699315 | Inhibition of TLR4 attenuates vascular dysfunction and oxidative stress in diabetic rats. |
| Q89598307 | Is the Arginase Pathway a Novel Therapeutic Avenue for Diabetic Retinopathy? |
| Q55153776 | Mechanisms of Diabetes-Induced Endothelial Cell Senescence: Role of Arginase 1. |
| Q34664336 | New approaches to the design and discovery of therapies to prevent erectile dysfunction |
| Q47734746 | Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1. |
| Q42819649 | Oxidative stress induces endothelial cell senescence via downregulation of Sirt6. |
| Q92921921 | Role of Arginase 2 in Murine Retinopathy Associated with Western Diet-Induced Obesity |
| Q36837617 | Role of arginase in vessel wall remodeling |
| Q64071750 | TRPV4 inhibition prevents increased water diffusion and blood-retina barrier breakdown in the retina of streptozotocin-induced diabetic mice |
Search more.